Trending Now
The FDA Endorses a Phase 1/2 Clinical Trial of NT219 from...
Kitov Pharma (NASDAQ:KTOV) has had a successful journey in advancing its first-in-class therapies, which overcome tumor immune evasion. Its long-lasting treatments for people with...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Moleculin Biotech Inc. (NASDAQ: MBRX) Announces Preliminary Results Of Study Evaluating...
Moleculin Biotech Inc. (NASDAQ: MBRX) has announced interim findings from the company’s US phase 1/2 study following the completion of a safety review of...
MAKE IT MODERN
LATEST REVIEWS
Onconova Therapeutics Inc. (NASDAQ: ONTX) Releases Safety And Efficacy Data of...
Onconova Therapeutics Inc. (NASDAQ: ONTX) has releases interim efficacy and safety data from the investigator-initiated Phase 1/2, a study of oral rigosertib combination with...
MAKE IT MODERN
PERFORMANCE TRAINING
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) To Present XPOVIO® Clinical Data At 2020 ESMO
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has announced the selection of four abstracts for poster presentation at the 2020 virtual European Society for Medical Oncology Congress.
Karyopharm...
Why did Dermata Therapeutics Inc (NASDAQ: DRMA) surge today ?
Dermata Therapeutics Inc (DRMA) saw an impressive rise in its stock price recently, despite the absence of any new public announcements. This...
Cerus Corporation (NASDAQ: CERS) Reports 41% YoY Revenue Growth In Q2 2021
Cerus Corporation (NASDAQ: CERS) has announced revenue of $37.8 million in Q2 2021, reflecting a 41% YoY increase. This was the highest quarterly total...
Invesco QQQ Trust Series 1 (NASDAQ:QQQ) continues higher as banking fears subside
The QQQ’s are finally starting to hold above the major $309 level and are continuing higher this morning. Bank fears are being...
GeoVax’s ($GOVX) Positive Trial News Sparks Surge in Stock Performance
Following the announcement of the significant funding and upcoming Phase 2b trial for their advanced COVID-19 vaccine, GEO-CM04S1, the stock of GeoVax...
MAKE IT MODERN
